The Immunosuppressive Drug LF15-0195 Acts Also on Glomerular Lesions, by a Change in Cytoskeleton Distribution in Podocyte.

IF 4.3 3区 医学 Q1 UROLOGY & NEPHROLOGY
American Journal of Nephrology Pub Date : 2024-01-01 Epub Date: 2024-07-29 DOI:10.1159/000539965
Ludmilla Le Berre, Gaëlle Tilly, Paul Pilet, Sophie Brouard, Jacques Dantal
{"title":"The Immunosuppressive Drug LF15-0195 Acts Also on Glomerular Lesions, by a Change in Cytoskeleton Distribution in Podocyte.","authors":"Ludmilla Le Berre, Gaëlle Tilly, Paul Pilet, Sophie Brouard, Jacques Dantal","doi":"10.1159/000539965","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Buffalo/Mna rats spontaneously develop nephrotic syndrome (NS) which recurs after renal transplantation. The immunosuppressive drug LF15-0195 can promote regression of the initial and post-transplantation nephropathy via induction of regulatory T cells. We investigate if this drug has an additional effect on the expression and localization of podocyte specific proteins.</p><p><strong>Methods: </strong>Buffalo/Mna kidney samples were collected before and after the occurrence of proteinuria, and after the remission of proteinuria induced by LF15-0195 treatment and compared by quantitative RT-PCR, Western blot, electron, and confocal microscopy to kidney samples of age-matched healthy rats. Cytoskeleton changes were assessed in culture by stress fibers induction by TNFα.</p><p><strong>Results: </strong>We observed, by electron microscopy, a restoration of foot process architecture in the LF15-0195-treated Buff/Mna kidneys, consistent with proteinuria remission. Nephrin, podocin, CD2AP, and α-actinin-4 mRNA levels remained low during the active disease in the Buff/Mna, in comparison with healthy rats which increase, while podocalyxin and synaptopodin transcripts were elevated before the occurrence of the disease but did not differ from healthy animals after. No difference in the mRNA and protein expression between the untreated and the LF15-0195-treated proteinuric Buff/Mna were seen for these 6 proteins. No changes were observed by confocal microscopy in the protein distribution at a cellular level, but a more homogenous distribution similar to healthy rats, was observed within the glomeruli of LF15-0195-treated rats. In addition, LF15-0195 could partially restore actin cytoskeleton of endothelial cells in TNFα-induced-cell stress experiment.</p><p><strong>Conclusion: </strong>The effect of LF15-0195 treatment appears to be mediated by 2 mechanisms: an immunomodulatory effect via regulatory T cells induction, described in our previous work and which can act on immune cell involved in the disease pathogenesis, and an effect on the restoration of podocyte cytoskeleton, independent of expression levels of the proteins involved in the slit diaphragm and podocyte function, showed in this article.</p>","PeriodicalId":7570,"journal":{"name":"American Journal of Nephrology","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000539965","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/29 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Buffalo/Mna rats spontaneously develop nephrotic syndrome (NS) which recurs after renal transplantation. The immunosuppressive drug LF15-0195 can promote regression of the initial and post-transplantation nephropathy via induction of regulatory T cells. We investigate if this drug has an additional effect on the expression and localization of podocyte specific proteins.

Methods: Buffalo/Mna kidney samples were collected before and after the occurrence of proteinuria, and after the remission of proteinuria induced by LF15-0195 treatment and compared by quantitative RT-PCR, Western blot, electron, and confocal microscopy to kidney samples of age-matched healthy rats. Cytoskeleton changes were assessed in culture by stress fibers induction by TNFα.

Results: We observed, by electron microscopy, a restoration of foot process architecture in the LF15-0195-treated Buff/Mna kidneys, consistent with proteinuria remission. Nephrin, podocin, CD2AP, and α-actinin-4 mRNA levels remained low during the active disease in the Buff/Mna, in comparison with healthy rats which increase, while podocalyxin and synaptopodin transcripts were elevated before the occurrence of the disease but did not differ from healthy animals after. No difference in the mRNA and protein expression between the untreated and the LF15-0195-treated proteinuric Buff/Mna were seen for these 6 proteins. No changes were observed by confocal microscopy in the protein distribution at a cellular level, but a more homogenous distribution similar to healthy rats, was observed within the glomeruli of LF15-0195-treated rats. In addition, LF15-0195 could partially restore actin cytoskeleton of endothelial cells in TNFα-induced-cell stress experiment.

Conclusion: The effect of LF15-0195 treatment appears to be mediated by 2 mechanisms: an immunomodulatory effect via regulatory T cells induction, described in our previous work and which can act on immune cell involved in the disease pathogenesis, and an effect on the restoration of podocyte cytoskeleton, independent of expression levels of the proteins involved in the slit diaphragm and podocyte function, showed in this article.

免疫抑制剂 LF15-0195 也通过改变荚膜细胞的细胞骨架分布,对肾小球病变产生作用。
引言水牛/Mna大鼠会自发出现肾病综合征(NS),并在肾移植后复发。免疫抑制剂LF15-0195可通过诱导调节性T细胞促进初期和移植后肾病的消退。我们研究了这种药物是否对荚膜特异性蛋白的表达和定位有额外影响:方法:在蛋白尿发生前后以及 LF15-0195 治疗诱导蛋白尿缓解后收集水牛/Mna 肾脏样本,并通过定量 RT-PCR、Western 印迹和显微镜与年龄匹配的健康大鼠肾脏样本进行比较。在培养过程中,通过 TNFα 诱导的应激纤维评估细胞骨架的变化:结果:我们通过电子显微镜观察到,经 LF15-0195 处理的 Buff/Mna 肾脏恢复了足突结构,这与蛋白尿的缓解相一致。Buff/Mna肾脏的肾素、荚膜素、CD2AP和α-actinin-4 mRNA水平在疾病活动期保持较低水平,而健康大鼠的mRNA水平则有所升高;荚膜萼蛋白和突触素转录本在疾病发生前升高,但在疾病发生后与健康动物无差异。未经处理的蛋白尿 Buff/Mna 与经 LF15-0195 处理的蛋白尿 Buff/Mna 在 mRNA 和蛋白质表达上没有差异。通过共聚焦显微镜观察,蛋白质在细胞水平上的分布没有变化,但在 LF15-0195 处理过的大鼠肾小球内,观察到与健康大鼠相似的更均匀的分布。此外,在TNFα诱导的细胞应激实验中,LF15-0195还能部分恢复内皮细胞的肌动蛋白细胞骨架:结论:LF15-0195治疗的效果似乎由两种机制介导:一种是通过诱导调节性T细胞产生免疫调节作用,这在我们之前的工作中已有描述,它可以作用于参与疾病发病机制的免疫细胞;另一种是对恢复荚膜细胞细胞骨架的影响,与本文中显示的参与裂隙隔膜和荚膜细胞功能的蛋白质的表达水平无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American Journal of Nephrology
American Journal of Nephrology 医学-泌尿学与肾脏学
CiteScore
7.50
自引率
2.40%
发文量
74
审稿时长
4-8 weeks
期刊介绍: The ''American Journal of Nephrology'' is a peer-reviewed journal that focuses on timely topics in both basic science and clinical research. Papers are divided into several sections, including:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信